Literature DB >> 7036713

Factor-X deficiency in amyloidosis: a critical review.

P R Greipp, R A Kyle, E J Bowie.   

Abstract

Thirty cases of amyloidosis with factor-X deficiency, including six of our own, were reviewed. Modest deficiency of factor X was often associated with severe bleeding. In many of the cases, clinical bleeding could not be accounted for by deficiency of factor X alone. Other hemostatic defects were found in these patients and probably contributed to the bleeding. Modes of treatment, including the empiric use of corticosteroids and splenectomy, were discussed in light of current knowledge of pathogenesis of this unusual blood clotting disorder. This involves the interaction of amyloid fibrils and blood clotting factors.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7036713     DOI: 10.1002/ajh.2830110414

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  25 in total

1.  Intracerebral haemorrhage in an adult due to transient factor X deficiency.

Authors:  T M Young; B P Chitnavis; E B Swallow; R Arya; B D Vadher
Journal:  J R Soc Med       Date:  2003-07       Impact factor: 5.344

2.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

3.  Hemorrhage because of amyloid-related factor X deficiency after insertion of Tenckhoff catheter.

Authors:  G Harman; B B McCormick
Journal:  Perit Dial Int       Date:  2012 Sep-Oct       Impact factor: 1.756

4.  Acquired factor V deficiency in a patient without evidence of a classical inhibitor.

Authors:  I R Sosa; P Ellery; A Mast; A T Neff; D Gailani
Journal:  Haemophilia       Date:  2013-10-14       Impact factor: 4.287

5.  Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis.

Authors:  Dino Veneri; Anna C Giuffrida; Angela Bonalumi; Stefano Calabria; Giorgio Gandini; Achille Ambrosetti; Pietro Minuz
Journal:  Blood Transfus       Date:  2016-05-24       Impact factor: 3.443

6.  [Systemic Al-amyloidosis. Clinical course and limits of melphalan therapy].

Authors:  G R Hetzel; P Heering; B Grabensee
Journal:  Med Klin (Munich)       Date:  1999-10-15

7.  Reversible functional asplenia and subcapsular liver hematoma--two distinctive manifestations of amyloidosis.

Authors:  E Levy-Lahad; D Steiner-Salz; N Berkman; R Chisin; P Levensart; E Leitersdorf
Journal:  Klin Wochenschr       Date:  1987-11-16

8.  Management of rare acquired bleeding disorders.

Authors:  Marzia Menegatti; Eugenia Biguzzi; Flora Peyvandi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 9.  Amyloidosis associated bleeding diatheses in the surgical patient.

Authors:  A R Mizutani; C F Ward
Journal:  Can J Anaesth       Date:  1990-11       Impact factor: 5.063

10.  Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

Authors:  Carrie A Thompson; Robert Kyle; Morie Gertz; John Heit; Rajiv Pruthi; Animesh Pardanani
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.